The director of IDIBAPS won the award for his contribution to the study of lymphoid neoplasms.
This Wednesday, the Hospital Clínic de Barcelona held an event to show its gratitude for all the expressions of solidarity received since the start o1
The presentation took place on Monday 17 May 2021 at the Royal Palace of El Pardo, in Madrid, at an event presided over by the King and Queen of Spai1
Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, with1
Spanish investigators from the IDIBAPS-Hospital Clínic of Barcelona have led an international effort to develop an epigenetic clock that is able to t1
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1
Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1
A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS of1
Researchers at IDIBAPS have published a study in Nature Communications in which they have deciphered the molecular basis of the genetic predispositio1
